T1	Concept 619 627	patients
T2	Concept 633 641	COVID-19
R1	in-context Arg1:T1 Arg2:T2	
T3	Concept 682 697	average numbers
T5	Concept 718 730	CD163+ cells
T4	Concept 701 713	CD163+ cells
R2	in-context Arg1:T3 Arg2:T4	
R3	in-context Arg1:T3 Arg2:T5	
T6	Concept 761 767	higher
T8	Action 605 613	reported
R6	target Arg1:T8 Arg2:T1	
T9	Concept 650 677	neurological manifestations
R7	has-property Arg1:T1 Arg2:T9	
T10	Concept 804 821	negative controls
R5	in-context Arg1:T6 Arg2:T10	
T7	Concept 775 785	ZIKV group
R4	in-context Arg1:T3 Arg2:T7	
R8	has-property Arg1:T7 Arg2:T6	
A1	Negated T1
T11	Concept 465 487	normal diploid genomes
T12	Concept 489 501	wild strains
T13	Concept 503 525	not inbred lab strains
*	same-as T11 T12 T13
T14	Concept 528 542	heterozygosity
T15	Concept 550 557	uniform
R9	has-property Arg1:T14 Arg2:T15	
A2	Negated T15
R11	in-context Arg1:T14 Arg2:T11	
T16	Concept 565 579	276 the genome
R10	in-place Arg1:T14 Arg2:T16	
T17	Action 228 236	suggests
T18	Action 269 277	decrease
T19	Action 388 401	corroborating
T20	Concept 34 50	Zika NS2B-NS3pro
T21	Concept 54 65	susceptible
R12	has-property Arg1:T20 Arg2:T21	
T22	Concept 69 90	allosteric inhibition
T23	Concept 115 124	molecules
T24	Concept 128 146	different scaffols
T25	Concept 109 114	small
T26	Concept 104 108	many
R13	has-property Arg1:T23 Arg2:T25	
R14	has-property Arg1:T23 Arg2:T26	
R15	has-property Arg1:T23 Arg2:T24	
R16	causes Arg1:T23 Arg2:T20	
A3	Uncertain T20
T27	Concept 161 171	estimation
T29	Concept 213 227	COVID-19 cases
T30	Concept 203 212	confirmed
R17	has-property Arg1:T29 Arg2:T30	
T31	Concept 197 202	newly
R18	has-property Arg1:T29 Arg2:T31	
T32	Concept 151 160	empirical
R21	has-property Arg1:T27 Arg2:T32	
R19	in-context Arg1:T27 Arg2:T29	
R20	subject Arg1:T17 Arg2:T27	
R22	target Arg1:T17 Arg2:T18	
T28	Concept 246 264	new infection case
R23	subject Arg1:T18 Arg2:T28	
T33	Concept 292 301	new cases
R24	target Arg1:T18 Arg2:T33	
T35	Concept 406 419	effectiveness
T36	Concept 423 442	China's large-scale
R27	target Arg1:T19 Arg2:T35	
R28	in-context Arg1:T35 Arg2:T36	
T37	Concept 305 318	0.097 (0.438)
R26	in-context Arg1:T18 Arg2:T37	
T34	Concept 326 355	following first (second) week
T38	Concept 363 386	February 2-15 subsample
R25	in-time Arg1:T18 Arg2:T34	
R29	in-context Arg1:T34 Arg2:T38	
R30	subject Arg1:T19 Arg2:T17	
